Stock RMDA TENTH OF RAMADAN FOR PHARMACEUTICAL INDUSTRIES AND DIAGNOSTIC REAGENTS (RAMEDA) S.A.E.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.

Equities

RMDA

EGS381B1C015

End-of-day quote Egyptian Exchange
Other stock markets
 06:00:00 2024-05-29 pm EDT 		5-day change 1st Jan Change
2.35 EGP +4.91% Intraday chart for Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. +9.30% +42.42%
May. 14 Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 19 Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Ekuity B.V. acquired additional 5.38% stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. for approximately EGP 160 million.
CI
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. announces an Equity Buyback for 10% of its issued share capital.
CI
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. authorizes a buyback plan.
CI
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
The Saudi Seventh Investment Company agreed to acquire additional 6.5% stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. for GGP 135 million.
CI
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents Rameda S.A.E. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
Equinox Pharma Holding Ltd. acquired additional 2.71% minority stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. for EGP 58.3 million.
CI
STenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Announce Audited Consolidated Earnings Results for the Quarter Ended March 31, 2021
CI
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents Rameda S.A.E. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents Rameda S.A.E. Reports Earnings Results for the Third Quarter Ended September 30, 2020
CI
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents Rameda S.A.E. Reports Earnings Results for the Second Quarter Ended June 30, 2020
CI
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. has completed an IPO in the amount of EGP 1.754984 billion.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RMDA Stock
  4. News Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.
  5. Highlights